2-236167566-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001485.4(GBX2):āc.406G>Cā(p.Gly136Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000796 in 1,597,906 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00053 ( 0 hom., cov: 32)
Exomes š: 0.00082 ( 1 hom. )
Consequence
GBX2
NM_001485.4 missense
NM_001485.4 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 0.763
Genes affected
GBX2 (HGNC:4186): (gastrulation brain homeobox 2) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of nervous system development and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; nervous system development; and neural crest cell migration. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14743325).
BS2
High AC in GnomAd4 at 81 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBX2 | NM_001485.4 | c.406G>C | p.Gly136Arg | missense_variant | 1/2 | ENST00000306318.5 | NP_001476.2 | |
GBX2 | NM_001301687.2 | c.406G>C | p.Gly136Arg | missense_variant | 1/3 | NP_001288616.1 | ||
GBX2 | XM_047443907.1 | c.406G>C | p.Gly136Arg | missense_variant | 1/4 | XP_047299863.1 | ||
GBX2-AS1 | NR_186035.1 | n.125C>G | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBX2 | ENST00000306318.5 | c.406G>C | p.Gly136Arg | missense_variant | 1/2 | 1 | NM_001485.4 | ENSP00000302251.4 |
Frequencies
GnomAD3 genomes AF: 0.000533 AC: 81AN: 152092Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
81
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000571 AC: 124AN: 217158Hom.: 0 AF XY: 0.000498 AC XY: 60AN XY: 120538
GnomAD3 exomes
AF:
AC:
124
AN:
217158
Hom.:
AF XY:
AC XY:
60
AN XY:
120538
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000824 AC: 1191AN: 1445706Hom.: 1 Cov.: 34 AF XY: 0.000801 AC XY: 576AN XY: 718796
GnomAD4 exome
AF:
AC:
1191
AN:
1445706
Hom.:
Cov.:
34
AF XY:
AC XY:
576
AN XY:
718796
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000532 AC: 81AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000417 AC XY: 31AN XY: 74416
GnomAD4 genome
AF:
AC:
81
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
57
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.406G>C (p.G136R) alteration is located in exon 1 (coding exon 1) of the GBX2 gene. This alteration results from a G to C substitution at nucleotide position 406, causing the glycine (G) at amino acid position 136 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;D
Sift4G
Benign
T;D
Polyphen
D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at